filmov
tv
Impact of specific mutations on PARP inhibition in prostate cancer
Показать описание
Emmanuel Antonarakis, MBBCh, of Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, speaks at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA. He dicusses a recent publication by his group on the impact of certain genes mutations on PARP inhibition in prostate cancer, including ATM, CDK12 and BRCA1/2.